ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Lipoatrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
2,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2,2,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
2,3,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
2,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
4,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
5,1,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
6,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
7,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
8,1,Fat necrosis,Necrosis NEC,Tissue disorders NEC,Genrl,N
9,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
10,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
10,2,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
11,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
11,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
11,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
12,1,Telangiectasia,Telangiectasia and related conditions,Skin vascular abnormalities,Skin,N
13,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
13,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
14,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
14,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
14,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
15,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
15,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
15,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
15,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
15,5,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
16,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
17,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
18,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
19,1,Tooth discolouration,Dental surface disorders,Dental and gingival conditions,Gastr,N
20,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
21,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
21,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
21,3,Renal pain,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
22,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
23,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
23,2,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
24,1,Renal cancer,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
25,1,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
25,2,Pneumonia herpes viral,Herpes viral infections,Viral infectious disorders,Infec,Y
26,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
27,1,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
28,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
29,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
29,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
30,1,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
30,2,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
31,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
32,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
32,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
33,1,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
34,1,Lipoatrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
35,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
36,1,Lipoatrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
36,2,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
37,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
38,1,Headache,Headaches NEC,Headaches,Nerv,N
38,2,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
38,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
39,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
40,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
41,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
42,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
43,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
44,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
45,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
46,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
47,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
47,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
47,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
48,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
48,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
49,1,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
50,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
51,1,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
51,2,Menstruation delayed,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
52,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
52,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
53,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
54,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
54,2,Migraine,Migraine headaches,Headaches,Nerv,N
54,3,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
55,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
56,1,Cervical radiculopathy,Cervical spinal cord and nerve root disorders,Spinal cord and nerve root disorders,Nerv,N
57,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
57,2,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
57,3,Pulse abnormal,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
58,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
58,2,Headache,Headaches NEC,Headaches,Nerv,N
59,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
60,1,Folliculitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
60,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
61,1,Type I hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
61,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
62,1,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
62,2,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
63,1,Bursitis,Bursal disorders,Synovial and bursal disorders,Musc,N
63,2,Staphylococcal sepsis,Staphylococcal infections,Bacterial infectious disorders,Infec,Y
64,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
64,2,Infection susceptibility increased,Infections NEC,Infections - pathogen unspecified,Infec,N
65,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
66,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
66,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
67,1,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
68,1,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
69,1,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
70,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
71,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
72,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
73,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
73,2,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
74,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
75,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
75,2,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
75,3,Serum sickness,Allergic conditions NEC,Allergic conditions,Immun,N
75,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
76,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
77,1,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
77,2,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
78,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
79,1,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
80,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
81,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
81,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
82,1,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
82,2,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
83,1,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
83,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
83,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
84,1,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
85,1,Laryngeal oedema,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
85,2,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
85,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
86,1,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
87,1,Headache,Headaches NEC,Headaches,Nerv,N
87,2,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
88,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
89,1,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
90,1,Oligospermia,Spermatogenesis and semen disorders,Sexual function and fertility disorders,Repro,N
91,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
92,1,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
93,1,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
94,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
95,1,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
95,2,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
96,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
97,1,Acute psychosis,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
98,1,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
99,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
99,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
99,3,Headache,Headaches NEC,Headaches,Nerv,N
100,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
101,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
102,1,Lacrimation disorder,Lacrimation disorders,Eye disorders NEC,Eye,N
102,2,Rhinitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
102,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
103,1,Tendon rupture,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
104,1,Tendon rupture,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
105,1,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
106,1,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
107,1,Gastric ulcer haemorrhage,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
108,1,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
109,1,Injection site necrosis,Injection site reactions,Administration site reactions,Genrl,N
110,1,Polymenorrhoea,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
111,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
112,1,Injection site necrosis,Injection site reactions,Administration site reactions,Genrl,N
113,1,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
114,1,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
115,1,Peripheral vascular disorder,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
116,1,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
117,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
118,1,Injection site necrosis,Injection site reactions,Administration site reactions,Genrl,N
119,1,Eye infection bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
119,2,Pleurisy,Pleural infections and inflammations,Pleural disorders,Resp,N
120,1,Injection site necrosis,Injection site reactions,Administration site reactions,Genrl,N
121,1,Injection site necrosis,Injection site reactions,Administration site reactions,Genrl,N
122,1,Skin striae,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
123,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
123,2,Hypothermia,Body temperature altered,Body temperature conditions,Genrl,N
123,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
124,1,Eye infection bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
125,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
126,1,Neoplasm,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
127,1,Neoplasm,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
128,1,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
129,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
130,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
131,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
131,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
131,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
132,1,Headache,Headaches NEC,Headaches,Nerv,N
133,1,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
134,1,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
135,1,Type 2 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
136,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
136,2,Increased bronchial secretion,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
136,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
136,4,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
137,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
138,1,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
139,1,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
140,1,Injection site necrosis,Injection site reactions,Administration site reactions,Genrl,N
141,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
142,1,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
143,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
143,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
143,3,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
144,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
145,1,Oral pigmentation,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
146,1,Coccydynia,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
147,1,Duodenal ulcer haemorrhage,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
148,1,Vitiligo,Hypopigmentation disorders,Pigmentation disorders,Skin,N
149,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
150,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
150,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
151,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
152,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
153,1,Acne,Acnes,Skin appendage conditions,Skin,N
154,1,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
155,1,Soft tissue injury,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
156,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
157,1,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
158,1,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
159,1,Acne,Acnes,Skin appendage conditions,Skin,N
160,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
161,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
161,2,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
162,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
163,1,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
163,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
164,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
165,1,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
166,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
167,1,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
168,1,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
168,2,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
169,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
169,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
169,3,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
170,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
170,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
170,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
171,1,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
172,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
173,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
174,1,Adrenal suppression,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
174,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
175,1,Headache,Headaches NEC,Headaches,Nerv,N
175,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
176,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
176,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
176,3,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
177,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
177,2,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
177,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
178,1,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
179,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
180,1,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
181,1,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
182,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
182,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
182,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
182,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
182,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
183,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
183,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
184,1,Depersonalisation/derealisation disorder,Dissociative states,Dissociative disorders,Psych,N
184,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
184,3,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
185,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
185,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
185,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
185,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
185,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
186,1,Vitiligo,Hypopigmentation disorders,Pigmentation disorders,Skin,N
187,1,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
188,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,Y
189,1,Vasoconstriction,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
190,1,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
190,2,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
191,1,Acne,Acnes,Skin appendage conditions,Skin,N
192,1,Skin depigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
193,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
193,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
194,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
194,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
194,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
195,1,Adrenal suppression,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
196,1,Injection site necrosis,Injection site reactions,Administration site reactions,Genrl,N
197,1,Pituitary tumour benign,Endocrine neoplasms benign NEC,Endocrine neoplasms benign,Neopl,N
198,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
198,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
199,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
200,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
200,2,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
201,1,Injection site necrosis,Injection site reactions,Administration site reactions,Genrl,N
202,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
203,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
204,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
205,1,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
206,1,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
207,1,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
208,1,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
209,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
210,1,Intracranial pressure increased,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
211,1,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
212,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
213,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
214,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
214,2,Skin depigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
215,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
216,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
217,1,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
218,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
219,1,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
220,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
221,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
222,1,Nasal dryness,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
223,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
224,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
225,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
226,1,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
226,2,Skin depigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
227,1,Headache,Headaches NEC,Headaches,Nerv,N
228,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
229,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
229,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
229,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
230,1,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
231,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
232,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
232,2,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
232,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
232,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
233,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
234,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
234,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
235,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
235,2,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
235,3,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
236,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
237,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
238,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
239,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
240,1,Delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
241,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
241,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
241,3,Lipoma,Soft tissue neoplasms benign NEC,Soft tissue neoplasms benign,Neopl,N
241,4,Neoplasm,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
242,1,Headache,Headaches NEC,Headaches,Nerv,N
242,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
242,3,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
242,4,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
243,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
244,1,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
244,2,Skin depigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
245,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,Y
245,2,Myopathy,Myopathies,Muscle disorders,Musc,N
245,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
245,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
246,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
247,1,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
248,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
248,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
248,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
248,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
248,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
249,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
249,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
249,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
249,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
249,5,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
249,6,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
250,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
250,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
251,1,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
251,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
251,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
252,1,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
253,1,Major depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
254,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
255,1,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
255,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
256,1,Ecchymosis,Purpura and related conditions,Skin vascular abnormalities,Skin,N
257,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
258,1,Myopathy,Myopathies,Muscle disorders,Musc,N
258,2,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
259,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
259,2,Anosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
260,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
261,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
262,1,Major depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
263,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
263,2,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
263,3,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
264,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
264,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
264,3,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
265,1,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
265,2,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
266,1,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
266,2,Oesophageal ulcer haemorrhage,Oesophageal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
266,3,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
266,4,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
267,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
268,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
269,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
269,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
269,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
270,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
270,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
270,3,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
270,4,Cystitis haemorrhagic,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
271,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
272,1,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
272,2,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
273,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
274,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
275,1,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
275,2,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
276,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
277,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
277,2,Uterine haemorrhage,Uterine disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
278,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
279,1,Adjustment disorder with depressed mood,Adjustment disorders,Adjustment disorders (incl subtypes),Psych,N
279,2,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
280,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
281,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
281,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
282,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
283,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
284,1,Application site oedema,Application site reactions,Administration site reactions,Genrl,N
285,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
286,1,Injection site necrosis,Injection site reactions,Administration site reactions,Genrl,N
286,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
286,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
287,1,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
288,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
288,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
288,3,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
288,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
288,5,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
289,1,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
290,1,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
291,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
291,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
291,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
292,1,Myopathy,Myopathies,Muscle disorders,Musc,N
293,1,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
294,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
295,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
296,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
296,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
297,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
298,1,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
299,1,Libido decreased,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
300,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
301,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
302,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
302,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
303,1,Headache,Headaches NEC,Headaches,Nerv,N
303,2,Toothache,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
304,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
305,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
305,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
305,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
305,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
306,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
307,1,Headache,Headaches NEC,Headaches,Nerv,N
308,1,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
309,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
309,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
310,1,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
311,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
312,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
313,1,Injection site necrosis,Injection site reactions,Administration site reactions,Genrl,N
314,1,Anorectal disorder,Anal and rectal disorders NEC,Anal and rectal conditions NEC,Gastr,N
314,2,Arachnoiditis,Central nervous system inflammatory disorders NEC,Central nervous system infections and inflammations,Nerv,N
314,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
314,4,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
314,5,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
314,6,Gastrointestinal motility disorder,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
314,7,Granuloma,Inflammations,General system disorders NEC,Genrl,N
314,8,Levator syndrome,Anal and rectal pains,Anal and rectal conditions NEC,Gastr,N
314,9,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
314,10,Nerve injury,Nerve injuries NEC,Injuries NEC,Inj&P,N
314,11,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
315,1,Rhinitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
315,2,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
316,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
316,2,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
316,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
317,1,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
317,2,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
318,1,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
319,1,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
320,1,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
321,1,Euphoric mood,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
322,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
322,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
322,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
323,1,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
324,1,Venous valve ruptured,Varicose veins NEC,Venous varices,Vasc,N
325,1,Application site oedema,Application site reactions,Administration site reactions,Genrl,N
325,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
325,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
326,1,Myopathy,Myopathies,Muscle disorders,Musc,N
326,2,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
327,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
328,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
329,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
330,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
331,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
331,2,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
331,3,Headache,Headaches NEC,Headaches,Nerv,N
331,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
331,5,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
331,6,Tongue oedema,Tongue signs and symptoms,Tongue conditions,Gastr,N
331,7,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
332,1,Myopathy,Myopathies,Muscle disorders,Musc,N
333,1,Abdominal hernia,Abdominal hernias NEC,Abdominal hernias and other abdominal wall conditions,Gastr,N
333,2,Pulmonary hypoplasia,Pulmonary and bronchial disorders congenital,Respiratory disorders congenital,Cong,Y
334,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
334,2,Headache,Headaches NEC,Headaches,Nerv,N
335,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
335,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
336,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
336,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
336,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
337,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
337,2,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
337,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
337,4,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
337,5,Rhinitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
338,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
339,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
339,2,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
339,3,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
339,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
339,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
340,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
340,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
340,3,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
340,4,Rhinitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
341,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
342,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
343,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
343,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
344,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
345,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
345,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
346,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
347,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
348,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
349,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
350,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
351,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
352,1,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
353,1,Headache,Headaches NEC,Headaches,Nerv,N
354,1,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
355,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
356,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
356,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
356,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
357,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
358,1,Pelvic inflammatory disease,Female reproductive tract infections,Infections - pathogen unspecified,Infec,N
359,1,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
360,1,Headache,Headaches NEC,Headaches,Nerv,N
360,2,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
361,1,Sinus pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
362,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
362,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
362,3,Headache,Headaches NEC,Headaches,Nerv,N
362,4,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
363,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
364,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
364,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
365,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
366,1,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
367,1,Pelvic inflammatory disease,Female reproductive tract infections,Infections - pathogen unspecified,Infec,N
368,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
369,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
370,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
370,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
370,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
371,1,Glucose tolerance impaired,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
371,2,Myopathy,Myopathies,Muscle disorders,Musc,N
371,3,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
371,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
372,1,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
373,1,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
374,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
375,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
376,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
377,1,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
378,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
379,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
379,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
379,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
380,1,Motor dysfunction,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
380,2,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
381,1,Motor dysfunction,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
381,2,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
382,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
382,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
382,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
383,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
384,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
385,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
385,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
386,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
387,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
388,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
389,1,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
389,2,Muscle injury,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
389,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
389,4,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
390,1,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
391,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
392,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
392,2,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
392,3,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
392,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
393,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
393,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
394,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
395,1,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
395,2,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
396,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
397,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
398,1,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
399,1,Glucocorticoids increased,Adrenal cortex tests,Endocrine investigations (incl sex hormones),Inv,N
400,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
400,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
401,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
402,1,Vitiligo,Hypopigmentation disorders,Pigmentation disorders,Skin,N
403,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
404,1,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
405,1,Adrenal suppression,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
405,2,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
406,1,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
407,1,Headache,Headaches NEC,Headaches,Nerv,N
408,1,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
408,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
409,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
410,1,Myopathy,Myopathies,Muscle disorders,Musc,N
410,2,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
411,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
412,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
413,1,Myopathy,Myopathies,Muscle disorders,Musc,N
413,2,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
414,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
414,2,Tendonitis,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
415,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
415,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
415,3,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
415,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
415,5,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
415,6,Ovarian disorder,Ovarian and fallopian tube disorders NEC,Ovarian and fallopian tube disorders,Repro,N
415,7,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
416,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
416,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
417,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
417,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
417,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
417,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
417,5,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
418,1,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
419,1,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
420,1,Acne,Acnes,Skin appendage conditions,Skin,N
421,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
421,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
421,3,Otitis externa,Ear infections,Infections - pathogen unspecified,Infec,N
422,1,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
423,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
424,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
424,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
424,3,Coma,Coma states,Neurological disorders NEC,Nerv,N
424,4,Paraplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
425,1,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
426,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
427,1,Cachexia,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
428,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
429,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
430,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
431,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
432,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
433,1,Adrenal suppression,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
433,2,Failure to thrive,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
433,3,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
434,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
435,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
436,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
437,1,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
437,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
438,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
438,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
439,1,Injection site necrosis,Injection site reactions,Administration site reactions,Genrl,N
440,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
441,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
441,2,Headache,Headaches NEC,Headaches,Nerv,N
441,3,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
442,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
442,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
443,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
443,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
444,1,Adrenal suppression,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
445,1,Adrenal suppression,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
445,2,Failure to thrive,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
446,1,Fat necrosis,Necrosis NEC,Tissue disorders NEC,Genrl,N
447,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
447,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
448,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
449,1,Polymyalgia rheumatica,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
450,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
450,2,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
451,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
451,2,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
451,3,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
452,1,Skin depigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
453,1,Adrenal suppression,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
453,2,Body height decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
453,3,Failure to thrive,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
454,1,Fat necrosis,Necrosis NEC,Tissue disorders NEC,Genrl,N
454,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
455,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
455,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
455,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
455,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
456,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
457,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
457,2,Biliary colic,Bile duct infections and inflammations,Bile duct disorders,Hepat,N
457,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
457,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
458,1,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
459,1,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
460,1,Abscess limb,Infections NEC,Infections - pathogen unspecified,Infec,N
461,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
462,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
462,2,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
463,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
464,1,Headache,Headaches NEC,Headaches,Nerv,N
465,1,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
466,1,Synovitis,Synovial disorders,Synovial and bursal disorders,Musc,N
467,1,Dry throat,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
467,2,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
468,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
469,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
469,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
470,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
471,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
471,2,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
471,3,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
471,4,Mouth swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
471,5,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
471,6,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
472,1,Adrenal suppression,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
472,2,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
473,1,Paraplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
473,2,Sciatica,Lumbar spinal cord and nerve root disorders,Spinal cord and nerve root disorders,Nerv,N
474,1,Piloerection,Pilar disorders NEC,Skin appendage conditions,Skin,N
474,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
475,1,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
475,2,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
476,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
476,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
476,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
476,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
476,5,Menstruation delayed,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
476,6,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
477,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
477,2,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
477,3,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
478,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
479,1,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
480,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
480,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
481,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
481,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
482,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
482,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
482,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
482,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
482,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
483,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
483,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
484,1,Tendon rupture,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
485,1,Necrotising scleritis,"Scleral infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
486,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
486,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
487,1,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
487,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
488,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
488,2,Injection site necrosis,Injection site reactions,Administration site reactions,Genrl,N
488,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
489,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
489,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
490,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
491,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
491,2,Feeling of body temperature change,Feelings and sensations NEC,General system disorders NEC,Genrl,N
491,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
491,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
492,1,Nerve block,Anaesthesia and allied procedures,Therapeutic procedures and supportive care NEC,Surg,N
493,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
493,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
493,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
494,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
494,2,Areflexia,Abnormal reflexes,Neurological disorders NEC,Nerv,N
494,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
494,4,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
494,5,Spinal cord infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
495,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
495,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
495,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
495,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
496,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
496,2,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
497,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
498,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
498,2,Multiple injuries,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
498,3,Road traffic accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,Y
499,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
500,1,Conjunctival haemorrhage,Conjunctival and corneal bleeding and vascular disorders,Ocular haemorrhages and vascular disorders NEC,Eye,N
501,1,Nasal septum perforation,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
501,2,Nasal ulcer,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
502,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
503,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
504,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
504,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
505,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
506,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
506,2,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
506,3,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
506,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
506,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
507,1,Anaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
507,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
507,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
508,1,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
509,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
510,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
510,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
510,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
510,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
511,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
512,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
513,1,Monoplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
513,2,Sensorimotor disorder,Neuromuscular disorders NEC,Neuromuscular disorders,Nerv,N
514,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
515,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
516,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
517,1,Renal pain,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
517,2,Sciatica,Lumbar spinal cord and nerve root disorders,Spinal cord and nerve root disorders,Nerv,N
518,1,Affect lability,Affect alterations NEC,Mood disorders and disturbances NEC,Psych,N
518,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
518,3,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
519,1,Monoplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
520,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
520,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
520,3,Peptic ulcer perforation,Peptic ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
520,4,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
521,1,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
521,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
522,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
522,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
522,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
523,1,Choking,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
523,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,Y
523,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
524,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
524,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
524,3,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
525,1,Anal injury,Abdominal and gastrointestinal injuries NEC,Injuries NEC,Inj&P,N
525,2,Arachnoiditis,Central nervous system inflammatory disorders NEC,Central nervous system infections and inflammations,Nerv,N
525,3,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
525,4,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
525,5,Gastrointestinal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
525,6,Granuloma,Inflammations,General system disorders NEC,Genrl,N
525,7,Hyperaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
525,8,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
525,9,Nerve injury,Nerve injuries NEC,Injuries NEC,Inj&P,N
525,10,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
525,11,Proctalgia,Anal and rectal pains,Anal and rectal conditions NEC,Gastr,N
525,12,Spinal cord injury,Spinal cord injuries NEC,Injuries NEC,Inj&P,N
526,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
526,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
526,3,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
526,4,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
527,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
528,1,Injection site scar,Injection site reactions,Administration site reactions,Genrl,N
529,1,Generalised oedema,Oedema NEC,General system disorders NEC,Genrl,N
529,2,Skin striae,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
530,1,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
530,2,Hair growth abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
530,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
531,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
531,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
531,3,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
531,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
532,1,Migraine,Migraine headaches,Headaches,Nerv,N
533,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
534,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
535,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
535,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
536,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
536,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
536,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
537,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
538,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
538,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
538,3,Food craving,Appetite disorders,Appetite and general nutritional disorders,Metab,N
538,4,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
538,5,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
538,6,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
538,7,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
539,1,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
540,1,Ischaemia,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
540,2,Limb injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
540,3,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
541,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
541,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
541,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
541,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
542,1,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
543,1,Arthritis infective,Bone and joint infections,Infections - pathogen unspecified,Infec,N
543,2,Periarthritis,Joint related disorders NEC,Joint disorders,Musc,N
544,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
544,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
544,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
545,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
545,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
545,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
546,1,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
546,2,Gingival swelling,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
546,3,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
546,4,Tongue haemorrhage,Tongue disorders,Tongue conditions,Gastr,N
547,1,Cataract subcapsular,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
547,2,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
547,3,Lens disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
547,4,Lenticular opacities,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
547,5,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
548,1,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
549,1,Peripheral ischaemia,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
550,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
551,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
551,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
551,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
551,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
551,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
552,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
552,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
553,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
553,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
554,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
554,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
554,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
554,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
555,1,Open globe injury,Eye injuries NEC,Injuries NEC,Inj&P,N
556,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
556,2,Conjunctival haemorrhage,Conjunctival and corneal bleeding and vascular disorders,Ocular haemorrhages and vascular disorders NEC,Eye,N
556,3,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
557,1,Eye abscess,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
558,1,Ocular hypertension,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
559,1,Ocular hypertension,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
560,1,Trigeminal neuralgia,Trigeminal disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
561,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
561,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
561,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
562,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
562,2,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
563,1,Arthritis infective,Bone and joint infections,Infections - pathogen unspecified,Infec,N
563,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
564,1,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
565,1,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
565,2,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
566,1,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
567,1,Auricular swelling,External ear disorders NEC,External ear disorders (excl congenital),Ear,N
567,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
567,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
567,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
568,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
568,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
568,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
568,4,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
568,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
568,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
568,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
568,8,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
568,9,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
569,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
570,1,Anovulatory cycle,Female gonadal function disorders,Endocrine disorders of gonadal function,Endo,N
570,2,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
570,3,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
570,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
571,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
572,1,Urinary tract infection viral,Viral infections NEC,Viral infectious disorders,Infec,N
573,1,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
574,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
575,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
575,2,Pituitary-dependent Cushing's syndrome,Anterior pituitary hyperfunction,Hypothalamus and pituitary gland disorders,Endo,N
576,1,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
577,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
577,2,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
577,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
578,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
578,2,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
579,1,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
579,2,Pelvic pain,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
580,1,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
580,2,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
581,1,Lipoatrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
582,1,Lipoatrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
582,2,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
583,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
584,1,Injection site vesicles,Injection site reactions,Administration site reactions,Genrl,N
585,1,Organ failure,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
586,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
587,1,Fear,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
588,1,Abscess jaw,Bone and joint infections,Infections - pathogen unspecified,Infec,N
588,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
588,3,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
589,1,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
590,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
590,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
591,1,Posterior capsule opacification,"Lens structural change, deposit and degeneration (excl cataracts)","Anterior eye structural change, deposit and degeneration",Eye,N
591,2,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
592,1,Hirsutism,Hypertrichoses,Skin appendage conditions,Skin,N
592,2,Pseudo Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
592,3,Skin striae,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
592,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
593,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
593,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
594,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
595,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
596,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
597,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
597,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
598,1,Skin depigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
599,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
599,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
599,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
599,4,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
599,5,Oropharyngeal blistering,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
600,1,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
601,1,Hypopyon,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
602,1,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
602,2,Hypopyon,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
603,1,Skin hypopigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
604,1,Application site pallor,Application site reactions,Administration site reactions,Genrl,N
604,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
604,3,Body dysmorphic disorder,Obsessive-compulsive disorders and symptoms,Anxiety disorders and symptoms,Psych,N
604,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
604,5,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
604,6,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
604,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
604,8,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
604,9,Social avoidant behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
605,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
605,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
605,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
606,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
607,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
607,2,Paraplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
608,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
608,2,Eye discharge,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
608,3,Optic atrophy,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
608,4,Pupillary reflex impaired,Pupil disorders,Ocular neuromuscular disorders,Eye,N
608,5,Retinal disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
608,6,Retinal vascular occlusion,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
608,7,Retinal vasculitis,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
608,8,Syphilis,Treponema infections,Bacterial infectious disorders,Infec,N
608,9,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
608,10,Vascular occlusion,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
609,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
609,2,Eye discharge,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
609,3,Eye inflammation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
609,4,Optic atrophy,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
609,5,Pupillary reflex impaired,Pupil disorders,Ocular neuromuscular disorders,Eye,N
609,6,Retinal vascular occlusion,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
609,7,Retinal vasculitis,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
609,8,Syphilis,Treponema infections,Bacterial infectious disorders,Infec,N
609,9,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
610,1,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
610,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
611,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
612,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
612,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
612,3,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
613,1,Migraine,Migraine headaches,Headaches,Nerv,N
613,2,Migraine with aura,Migraine headaches,Headaches,Nerv,N
614,1,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
615,1,Hypopyon,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
615,2,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
616,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
616,2,Blood pressure fluctuation,Blood pressure disorders NEC,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
616,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
616,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
617,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
617,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
617,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
617,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
617,5,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
617,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
617,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
618,1,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
618,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
619,1,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
619,2,Skin depigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
620,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
620,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
620,3,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
620,4,Urine viscosity abnormal,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
621,1,Eye infection,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
621,2,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
621,3,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
621,4,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
622,1,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
622,2,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
623,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
624,1,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
624,2,Periarthritis,Joint related disorders NEC,Joint disorders,Musc,N
625,1,Complex regional pain syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
625,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
625,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
625,4,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
626,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
626,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
626,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
627,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
627,2,Headache,Headaches NEC,Headaches,Nerv,N
628,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
628,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
629,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
629,2,Nasal dryness,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
629,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
629,4,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
629,5,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
630,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
631,1,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
632,1,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
632,2,Iridocyclitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
633,1,Lipoatrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
634,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
635,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
636,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
636,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
637,1,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
637,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
637,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
637,4,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
637,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
638,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
638,2,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
639,1,Lipoatrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
640,1,Lipoatrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
641,1,Lipoatrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
642,1,Lipoatrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
643,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
644,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
645,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
645,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
645,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
645,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
645,5,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
646,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
646,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
646,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
647,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
647,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
647,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
648,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
648,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
649,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
650,1,Arteritis,Arterial infections and inflammations,Vascular infections and inflammations,Vasc,N
650,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
650,3,Corneal lesion,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
650,4,Eye infection toxoplasmal,Toxoplasma infections,Protozoal infectious disorders,Infec,N
650,5,Eye inflammation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
650,6,Fibrosis,Fibrosis NEC,Tissue disorders NEC,Genrl,N
650,7,Necrotising retinitis,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
650,8,Retinal detachment,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
650,9,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
650,10,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
651,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
651,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
651,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
652,1,Adrenal suppression,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
652,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
652,3,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
653,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
653,2,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
653,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
653,4,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
653,5,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
654,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
654,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
654,3,Headache,Headaches NEC,Headaches,Nerv,N
654,4,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
655,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
655,2,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
655,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
656,1,Nasal septum perforation,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
657,1,Hyperventilation,Breathing abnormalities,Respiratory disorders NEC,Resp,N
657,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
658,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
658,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
658,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
659,1,Allergy test positive,Immunology analyses NEC,Immunology and allergy investigations,Inv,N
659,2,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
659,3,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
659,4,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
659,5,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
659,6,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
659,7,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
659,8,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
659,9,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
659,10,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
659,11,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
659,12,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
659,13,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
659,14,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
659,15,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
660,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
661,1,Acne,Acnes,Skin appendage conditions,Skin,N
661,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
662,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
662,2,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
662,3,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
663,1,Pseudo Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
664,1,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
665,1,Adrenal suppression,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
666,1,Adrenal suppression,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
667,1,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
667,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
668,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
668,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
669,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
669,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
669,3,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
669,4,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
669,5,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
669,6,Joint range of motion decreased,Joint related signs and symptoms,Joint disorders,Musc,N
669,7,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
669,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
669,9,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
669,10,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
669,11,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
669,12,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
670,1,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
670,2,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
670,3,Skin injury,Skin injuries NEC,Injuries NEC,Inj&P,N
671,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
672,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
673,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
674,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
674,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
674,3,Joint warmth,Joint related signs and symptoms,Joint disorders,Musc,N
674,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
674,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
675,1,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
676,1,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
677,1,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
678,1,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
679,1,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
680,1,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
681,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
681,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
681,3,Arachnoiditis,Central nervous system inflammatory disorders NEC,Central nervous system infections and inflammations,Nerv,N
681,4,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
681,5,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
681,6,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
681,7,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
681,8,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
681,9,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
681,10,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
681,11,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
681,12,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
681,13,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
681,14,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
681,15,Spinal cord injury cauda equina,Spinal cord injuries NEC,Injuries NEC,Inj&P,N
681,16,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
682,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
683,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
683,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
683,3,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
683,4,Cauda equina syndrome,Lumbar spinal cord and nerve root disorders,Spinal cord and nerve root disorders,Nerv,N
683,5,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
683,6,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
683,7,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
683,8,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
683,9,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
683,10,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
683,11,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
683,12,Pruritus allergic,Pruritus NEC,Epidermal and dermal conditions,Skin,N
683,13,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
683,14,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
684,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
685,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
685,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
686,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
686,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
686,3,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
687,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
688,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
688,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
689,1,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
689,2,Hunger,Feelings and sensations NEC,General system disorders NEC,Genrl,N
689,3,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
690,1,Anaesthetic complication,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
690,2,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
690,3,Headache,Headaches NEC,Headaches,Nerv,N
690,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
690,5,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
690,6,Pneumocephalus,Neurological and psychiatric procedural complications,Procedural related injuries and complications NEC,Inj&P,N
691,1,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
692,1,Atrophy,Trophic disorders,Tissue disorders NEC,Genrl,N
692,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
693,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
694,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
694,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
694,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
695,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
696,1,Abnormal withdrawal bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
697,1,Acne,Acnes,Skin appendage conditions,Skin,N
697,2,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
697,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
697,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
697,5,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
697,6,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
698,1,Adrenal suppression,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
698,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
698,3,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
699,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
700,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
700,2,Injection site cyst,Injection site reactions,Administration site reactions,Genrl,N
700,3,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
700,4,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
700,5,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
700,6,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
700,7,Wound secretion,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
701,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
702,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
702,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
702,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
703,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
703,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
704,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
705,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
705,2,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
705,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
706,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
706,2,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
706,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
707,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
707,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
707,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
707,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
707,5,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
708,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
708,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
708,3,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
709,1,Central obesity,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
709,2,Cortisol decreased,Adrenal cortex tests,Endocrine investigations (incl sex hormones),Inv,N
709,3,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
709,4,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
709,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
709,6,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
709,7,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
710,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
710,2,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
710,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
711,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
712,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
712,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
712,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
712,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
713,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
713,2,Retinal vein occlusion,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
714,1,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
714,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
714,3,Fat tissue increased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
714,4,Hirsutism,Hypertrichoses,Skin appendage conditions,Skin,N
714,5,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
714,6,Hyperosmolar state,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
714,7,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
715,1,Glossodynia,Tongue signs and symptoms,Tongue conditions,Gastr,N
715,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
715,3,Oral papule,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
715,4,Tongue discolouration,Tongue signs and symptoms,Tongue conditions,Gastr,N
716,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
716,2,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
717,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
718,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
718,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
718,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
718,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
718,5,Type I hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
719,1,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
719,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
720,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
720,2,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
721,1,Adrenal suppression,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
721,2,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
722,1,Arterial spasm,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
723,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
723,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
723,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
723,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
723,5,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
723,6,Skin depigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
724,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
724,2,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
724,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
724,4,Injection site joint warmth,Injection site reactions,Administration site reactions,Genrl,N
724,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
725,1,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
725,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
725,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
725,4,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
725,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
725,6,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
726,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
726,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
726,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
726,4,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
726,5,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
726,6,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
726,7,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
727,1,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
727,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
727,3,Retrograde ejaculation,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
728,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
729,1,Tongue discolouration,Tongue signs and symptoms,Tongue conditions,Gastr,N
730,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
730,2,Livedo reticularis,Skin vasomotor conditions,Skin vascular abnormalities,Skin,N
730,3,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
730,4,Vascular occlusion,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
731,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
731,2,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
732,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
732,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
733,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
733,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
733,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
733,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
733,5,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
733,6,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
734,1,Injection site discolouration,Injection site reactions,Administration site reactions,Genrl,N
734,2,Lipoatrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
735,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
735,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
735,3,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
736,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
736,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
736,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
736,4,Immediate post-injection reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
736,5,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
736,6,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
736,7,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
737,1,Deafness transitory,Hearing losses,Hearing disorders,Ear,N
737,2,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
737,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
737,4,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
737,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
737,6,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
737,7,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
737,8,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
738,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
739,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
739,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
739,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
740,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
741,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
742,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
742,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
743,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
744,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
744,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
745,1,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
746,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
746,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
746,3,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
746,4,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
746,5,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
746,6,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
746,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
747,1,Arrhythmia supraventricular,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
748,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
749,1,Genital rash,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
749,2,Pruritus genital,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
750,1,Eyelid ptosis,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
750,2,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
750,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
751,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
751,2,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
751,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
751,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
751,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
751,6,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
751,7,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
752,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
753,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
753,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
754,1,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
754,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
755,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
755,2,Rosacea,Rosaceas,Skin appendage conditions,Skin,N
756,1,Bone tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
757,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
758,1,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
758,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
759,1,Adrenal suppression,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
760,1,Adrenal suppression,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
761,1,Adrenal suppression,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
762,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
762,2,Blood glucose abnormal,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
762,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
762,4,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
762,5,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
762,6,Functional gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
762,7,Hypervigilance,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
762,8,Hypohidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
762,9,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
762,10,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
762,11,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
762,12,Myalgia,Muscle pains,Muscle disorders,Musc,N
762,13,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
762,14,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
762,15,Tendon disorder,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
762,16,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
762,17,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
763,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
763,2,Headache,Headaches NEC,Headaches,Nerv,N
764,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
765,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
765,2,Headache,Headaches NEC,Headaches,Nerv,N
765,3,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
765,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
766,1,Headache,Headaches NEC,Headaches,Nerv,N
766,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
767,1,Blood HIV RNA increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
767,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
767,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
767,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
768,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
769,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
770,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
770,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
771,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
771,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
771,3,Facial pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
771,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
771,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
771,6,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
771,7,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
771,8,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
772,1,Poor peripheral circulation,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
773,1,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
774,1,Blood HIV RNA increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
774,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
774,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
775,1,Bone density decreased,Musculoskeletal and soft tissue imaging procedures,Musculoskeletal and soft tissue investigations (excl enzyme tests),Inv,N
776,1,Soft tissue atrophy,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
777,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
777,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
777,3,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
778,1,Anorectal disorder,Anal and rectal disorders NEC,Anal and rectal conditions NEC,Gastr,N
778,2,Arachnoiditis,Central nervous system inflammatory disorders NEC,Central nervous system infections and inflammations,Nerv,N
778,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
778,4,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
778,5,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
778,6,Ear disorder,Ear disorders NEC,Aural disorders NEC,Ear,N
778,7,Gastrointestinal motility disorder,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
778,8,Granuloma,Inflammations,General system disorders NEC,Genrl,N
778,9,Levator syndrome,Anal and rectal pains,Anal and rectal conditions NEC,Gastr,N
778,10,Muscle strain,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
778,11,Nerve injury,Nerve injuries NEC,Injuries NEC,Inj&P,N
778,12,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
778,13,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
778,14,Polyp,Mucosal findings abnormal,General system disorders NEC,Genrl,N
778,15,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
779,1,Vitreous detachment,"Choroid and vitreous structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
780,1,Cortisol decreased,Adrenal cortex tests,Endocrine investigations (incl sex hormones),Inv,N
780,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
780,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
780,4,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
780,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
781,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
781,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
782,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
783,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
784,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
785,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
785,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
786,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
787,1,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
787,2,Skin depigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
788,1,Headache,Headaches NEC,Headaches,Nerv,N
788,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
789,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
789,2,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
789,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
789,4,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
789,5,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
789,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
789,7,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
789,8,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
789,9,Pharyngeal hypoaesthesia,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
789,10,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
790,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
790,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
791,1,Arachnoiditis,Central nervous system inflammatory disorders NEC,Central nervous system infections and inflammations,Nerv,N
791,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
791,3,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
791,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
792,1,Gastric haemorrhage,Gastric and oesophageal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
793,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
794,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
794,2,Reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
795,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
795,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
795,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
795,4,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
795,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
796,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
796,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
797,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
798,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
798,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
799,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
799,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
799,3,Dry throat,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
799,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
799,5,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
799,6,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
799,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
799,8,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
800,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
800,2,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
800,3,Ocular vascular disorder,Ocular bleeding and vascular disorders NEC,Ocular haemorrhages and vascular disorders NEC,Eye,N
800,4,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
801,1,Retinal detachment,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
801,2,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
802,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
802,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
802,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
802,4,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
803,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
803,2,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
803,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
804,1,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
804,2,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
804,3,Mental status changes,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
804,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
805,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
805,2,Retinal detachment,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
805,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
806,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
806,2,Eye haemorrhage,Ocular bleeding and vascular disorders NEC,Ocular haemorrhages and vascular disorders NEC,Eye,N
806,3,Vascular injury,Cardiovascular injuries,Injuries NEC,Inj&P,N
807,1,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
807,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
808,1,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
808,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
809,1,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
809,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
810,1,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
810,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
811,1,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
811,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
812,1,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
812,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
813,1,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
813,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
813,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
814,1,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
814,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
815,1,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
815,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
815,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
816,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
816,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
817,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
817,2,Grunting,Breathing abnormalities,Respiratory disorders NEC,Resp,N
817,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
818,1,Lipoatrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
819,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
819,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
819,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
819,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
820,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
821,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
821,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
822,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
823,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
824,1,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
825,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
825,2,Periorbital swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
825,3,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
825,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
826,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
826,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
827,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
827,2,Periorbital swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
827,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
827,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
828,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
829,1,Blindness unilateral,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
830,1,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
831,1,Staphylococcal bacteraemia,Staphylococcal infections,Bacterial infectious disorders,Infec,N
832,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
832,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
833,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
834,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
834,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
834,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
835,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
835,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
836,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
836,2,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
836,3,Lipoma,Soft tissue neoplasms benign NEC,Soft tissue neoplasms benign,Neopl,N
837,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
837,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
838,1,Adrenal suppression,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
838,2,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
838,3,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
839,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
839,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
839,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
839,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
839,5,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
839,6,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
839,7,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
839,8,Headache,Headaches NEC,Headaches,Nerv,N
839,9,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
839,10,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
839,11,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
839,12,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
839,13,Reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
840,1,Product lot number issue,Product label issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
840,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
841,1,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
841,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
842,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
843,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
844,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
844,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
844,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
845,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
845,2,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
845,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
845,4,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
845,5,Lipohypertrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
845,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
845,7,Skin striae,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
845,8,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
846,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
846,2,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
847,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
847,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
847,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
847,4,Livedo reticularis,Skin vasomotor conditions,Skin vascular abnormalities,Skin,N
847,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
848,1,Adrenal suppression,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
848,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
849,1,Adrenal suppression,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
849,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
850,1,Adrenal suppression,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
850,2,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
850,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
851,1,Adrenal suppression,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
851,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
852,1,Adrenal suppression,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
852,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
853,1,Adrenal suppression,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
853,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
854,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
854,2,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
854,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
855,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
856,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
856,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
857,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
857,2,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
857,3,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
858,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
858,2,Cortisol increased,Adrenal cortex tests,Endocrine investigations (incl sex hormones),Inv,N
858,3,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
858,4,Hyperacusis,Hyperacusia,Hearing disorders,Ear,N
858,5,Hypohidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
858,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
858,7,Myalgia,Muscle pains,Muscle disorders,Musc,N
858,8,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
858,9,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
858,10,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
858,11,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
859,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
859,2,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
860,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
860,2,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
861,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
861,2,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
862,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
862,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
862,3,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
863,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
863,2,Mycobacterium marinum infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
863,3,Osteomyelitis,Bone and joint infections,Infections - pathogen unspecified,Infec,N
864,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
865,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
866,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
866,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
867,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
868,1,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
869,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
869,2,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
869,3,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
869,4,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
869,5,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
869,6,Dissociative amnesia,Dissociative states,Dissociative disorders,Psych,N
869,7,Dysgraphia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
869,8,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
869,9,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
869,10,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
869,11,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
869,12,Headache,Headaches NEC,Headaches,Nerv,N
869,13,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
869,14,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
869,15,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
869,16,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
869,17,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
869,18,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
869,19,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
869,20,Mydriasis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
869,21,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
869,22,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
869,23,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
869,24,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
869,25,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
869,26,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
869,27,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
869,28,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
869,29,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
869,30,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
870,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
871,1,Adrenal suppression,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
871,2,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
871,3,Pseudo Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
872,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
872,2,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
872,3,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
873,1,Bone swelling,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
873,2,Lipoatrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
873,3,Skin depigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
874,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
874,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
875,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
876,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
877,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
878,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
878,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
879,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
880,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
881,1,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
882,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
883,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
883,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
883,3,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
883,4,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
884,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
884,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
884,3,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
885,1,Skin depigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
886,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
887,1,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
887,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
887,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
888,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
889,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
889,2,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
889,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
890,1,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
890,2,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
891,1,Bone erosion,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
892,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
892,2,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
893,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
893,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
893,3,Pneumonia bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
893,4,Prescribed overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
893,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
893,6,Spinal pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
893,7,Traumatic renal injury,Renal and urinary tract injuries NEC,Injuries NEC,Inj&P,N
893,8,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
894,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
895,1,Lipoatrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
895,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
895,3,Skin depigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
896,1,Postmenopausal haemorrhage,Menopausal effects on the genitourinary tract,Menopause related conditions,Repro,N
897,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
897,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
897,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
898,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
898,2,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
898,3,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
898,4,Dizziness postural,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
898,5,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
898,6,Glycosuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
898,7,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
898,8,Myopathy,Myopathies,Muscle disorders,Musc,N
898,9,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
898,10,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
899,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
899,2,Acne,Acnes,Skin appendage conditions,Skin,N
899,3,Cortisol decreased,Adrenal cortex tests,Endocrine investigations (incl sex hormones),Inv,N
899,4,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
899,5,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
899,6,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
899,7,Increased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
900,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
901,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
901,2,Skin depigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
902,1,Migraine,Migraine headaches,Headaches,Nerv,N
902,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
903,1,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
903,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
903,3,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
904,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
904,2,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
904,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
905,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
905,2,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
905,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
906,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
906,2,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
906,3,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
907,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
907,2,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
907,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
908,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
908,2,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
908,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
909,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
909,2,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
909,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
910,1,Duodenal perforation,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
910,2,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
911,1,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
911,2,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
911,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
912,1,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
912,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
912,3,Hirsutism,Hypertrichoses,Skin appendage conditions,Skin,N
912,4,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
912,5,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
913,1,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
913,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
913,3,Myopathy,Myopathies,Muscle disorders,Musc,N
913,4,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
914,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
914,2,Arthrotomy,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
914,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
914,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
914,5,Streptococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
915,1,Lipoatrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
915,2,Skin depigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
916,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
917,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
917,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
917,3,Streptococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
918,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
918,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
918,3,Heart rate irregular,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
919,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
919,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
920,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
920,2,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
920,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
920,4,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
921,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
921,2,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
921,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
921,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
921,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
922,1,Injection site necrosis,Injection site reactions,Administration site reactions,Genrl,N
923,1,Cortisol decreased,Adrenal cortex tests,Endocrine investigations (incl sex hormones),Inv,N
923,2,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
923,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
923,4,Oropharyngeal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
923,5,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
923,6,Wrong product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
924,1,Median nerve injury,Peripheral nerve injuries,Injuries NEC,Inj&P,N
925,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
925,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
925,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
926,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
926,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
927,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
927,2,Post procedural complication,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
928,1,Postmenopausal haemorrhage,Menopausal effects on the genitourinary tract,Menopause related conditions,Repro,N
929,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
929,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
929,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
930,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
930,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
930,3,Injection related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
930,4,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
930,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
930,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
930,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
931,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
932,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
933,1,Eye inflammation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
933,2,Hypopyon,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
934,1,Postmenopausal haemorrhage,Menopausal effects on the genitourinary tract,Menopause related conditions,Repro,N
935,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
936,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
936,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
937,1,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
937,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
938,1,Skin depigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
939,1,Lipoatrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
939,2,Skin depigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
940,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
941,1,Acne,Acnes,Skin appendage conditions,Skin,N
942,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
942,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
942,3,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
942,4,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
942,5,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
942,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
942,7,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
942,8,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
942,9,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
942,10,Thinking abnormal,Thinking disturbances,Disturbances in thinking and perception,Psych,N
943,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
943,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
943,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
944,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
944,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
944,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
945,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
945,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
945,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
946,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
946,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
946,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
947,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
947,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
947,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
948,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
948,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
948,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
949,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
949,2,Partial seizures,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
949,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
950,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
950,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
951,1,Headache,Headaches NEC,Headaches,Nerv,N
951,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
952,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
953,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
953,2,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
953,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
954,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
954,2,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
954,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
954,4,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
954,5,Skin indentation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
955,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
955,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
956,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
956,2,Arthritis infective,Bone and joint infections,Infections - pathogen unspecified,Infec,N
956,3,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
957,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
958,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
959,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
959,2,Feeling jittery,Feelings and sensations NEC,General system disorders NEC,Genrl,N
960,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
961,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
962,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
962,2,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
962,3,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
962,4,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
962,5,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
962,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
962,7,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
962,8,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
962,9,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
962,10,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
963,1,Injection site calcification,Injection site reactions,Administration site reactions,Genrl,N
963,2,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
963,3,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
964,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
964,2,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
965,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
965,2,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
965,3,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
965,4,Maculopathy,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
966,1,Injection site extravasation,Injection site reactions,Administration site reactions,Genrl,N
966,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
966,3,Product administered at inappropriate site,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
966,4,Skin depigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
966,5,Vascular pseudoaneurysm,Cardiac and vascular procedural complications,Procedural related injuries and complications NEC,Inj&P,N
967,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
967,2,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
967,3,Mycobacterium kansasii infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
967,4,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
967,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
967,6,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
967,7,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
967,8,Tendon rupture,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
967,9,Tenosynovitis,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
967,10,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
968,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
969,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
969,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
969,3,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
969,4,Product preparation error,Product preparation errors and issues,Medication errors and other product use errors and issues,Inj&P,N
969,5,Wrong product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
970,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
970,2,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
970,3,Injection site haematoma,Injection site reactions,Administration site reactions,Genrl,N
970,4,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
970,5,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
971,1,Inadequate aseptic technique in use of product,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
971,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
972,1,Skin depigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
973,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
974,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
974,2,Injection site vesicles,Injection site reactions,Administration site reactions,Genrl,N
974,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
974,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
974,5,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
975,1,Headache,Headaches NEC,Headaches,Nerv,N
976,1,Vasoconstriction,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
977,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
977,2,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
977,3,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
977,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
977,5,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
977,6,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
978,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
978,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
978,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
978,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
978,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
978,6,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
979,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
979,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
979,3,Headache,Headaches NEC,Headaches,Nerv,N
979,4,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
979,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
979,6,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
979,7,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
980,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
981,1,Eyelid ptosis,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
981,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
982,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
983,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
983,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
983,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
984,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
985,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
986,1,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
987,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
987,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
987,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
988,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
988,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
988,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
988,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
988,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
989,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
989,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
989,3,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
989,4,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
989,5,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
989,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
989,7,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
989,8,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
990,1,Blindness unilateral,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
990,2,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
991,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
992,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
993,1,Injection site necrosis,Injection site reactions,Administration site reactions,Genrl,N
994,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
994,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
994,3,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
995,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
995,2,Non-infectious endophthalmitis,Chambers (anterior and posterior) and lens infections and inflammations,"Ocular infections, irritations and inflammations",Eye,N
996,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
996,2,Non-infectious endophthalmitis,Chambers (anterior and posterior) and lens infections and inflammations,"Ocular infections, irritations and inflammations",Eye,N
997,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
998,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
998,2,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
998,3,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
998,4,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
999,1,Injection site indentation,Injection site reactions,Administration site reactions,Genrl,N
1000,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1000,2,Skin depigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
1001,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1001,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1001,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1001,4,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1001,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1001,6,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1001,7,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
1001,8,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1002,1,Adrenal suppression,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1002,2,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1002,3,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1003,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1003,2,Postmenopausal haemorrhage,Menopausal effects on the genitourinary tract,Menopause related conditions,Repro,N
1004,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1005,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1005,2,Bone disorder,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1005,3,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1005,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1005,5,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1005,6,Soft tissue swelling,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1005,7,Ulna fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1006,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1006,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
1007,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1008,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1008,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1008,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1009,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1009,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1009,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1010,1,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
1010,2,Polymenorrhoea,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
1011,1,Injection site dryness,Injection site reactions,Administration site reactions,Genrl,N
1011,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
1011,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1012,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1012,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1013,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1014,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1014,2,Headache,Headaches NEC,Headaches,Nerv,N
1014,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1014,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1015,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1015,2,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1015,3,Drug clearance decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1015,4,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1015,5,Hypovolaemia,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1015,6,Pseudo Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1015,7,Urine output decreased,Urinary tract function analyses NEC,Renal and urinary tract investigations and urinalyses,Inv,N
1016,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1017,1,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
1017,2,Injection site discolouration,Injection site reactions,Administration site reactions,Genrl,N
1017,3,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
1018,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1018,2,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1018,3,Hepatic pain,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
1018,4,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1018,5,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1019,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1020,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1021,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1021,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1022,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1023,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1024,1,Raynaud's phenomenon,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1024,2,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1025,1,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
1026,1,Adrenal suppression,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1027,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1027,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1027,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1027,4,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
1027,5,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1027,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1027,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1028,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1028,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1028,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1028,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1028,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1029,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1029,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1029,3,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1029,4,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
1029,5,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1029,6,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1029,7,Dural tear,Neurological and psychiatric procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1029,8,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1029,9,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1029,10,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1029,11,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1029,12,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1029,13,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1029,14,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1029,15,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
1029,16,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1029,17,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1029,18,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1029,19,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1029,20,Paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1029,21,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
1029,22,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1029,23,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1029,24,Toothache,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
1029,25,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1030,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
1030,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1031,1,Adrenal suppression,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1031,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1032,1,Electric shock sensation,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1032,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
1032,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1032,4,Headache,Headaches NEC,Headaches,Nerv,N
1032,5,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1033,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1033,2,Increased steroid activity,Adrenal cortex tests,Endocrine investigations (incl sex hormones),Inv,N
1034,1,Iritis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
1034,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1035,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1036,1,Ear swelling,Ear disorders NEC,Aural disorders NEC,Ear,N
1036,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1037,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1038,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1038,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1039,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1040,1,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1040,2,Panic reaction,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
1041,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1041,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1041,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1042,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1043,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1043,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1044,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
1045,1,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
1045,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1045,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1046,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1047,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1048,1,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1048,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
1048,3,Osteomyelitis,Bone and joint infections,Infections - pathogen unspecified,Infec,N
1048,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1049,1,Electric shock sensation,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1049,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1049,3,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1049,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1050,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1050,2,Herpes simplex reactivation,Herpes viral infections,Viral infectious disorders,Infec,N
1050,3,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1050,4,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1050,5,Varicella zoster virus infection,Herpes viral infections,Viral infectious disorders,Infec,N
1051,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1051,2,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1051,3,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1051,4,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1051,5,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1051,6,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1051,7,Angle closure glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
1051,8,Anterior chamber inflammation,Chambers (anterior and posterior) and lens infections and inflammations,"Ocular infections, irritations and inflammations",Eye,N
1051,9,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1051,10,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1051,11,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1051,12,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1051,13,Blindness unilateral,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1051,14,Blindness unilateral,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1051,15,Cellulitis orbital,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1051,16,Cellulitis orbital,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1051,17,Central vision loss,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1051,18,Central vision loss,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1051,19,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1051,20,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
1051,21,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1051,22,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1051,23,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1051,24,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1051,25,Epiretinal membrane,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
1051,26,Eye infection,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
1051,27,Eye infection,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
1051,28,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
1051,29,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
1051,30,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1051,31,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1051,32,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1051,33,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
1051,34,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
1051,35,Headache,Headaches NEC,Headaches,Nerv,N
1051,36,Headache,Headaches NEC,Headaches,Nerv,N
1051,37,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1051,38,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1051,39,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1051,40,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1051,41,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1051,42,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1051,43,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
1051,44,Macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
1051,45,Macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
1051,46,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1051,47,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1051,48,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1051,49,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1051,50,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1051,51,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1051,52,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1051,53,Psychiatric symptom,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1051,54,Psychiatric symptom,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1051,55,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1051,56,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1051,57,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1051,58,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1051,59,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1051,60,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
1051,61,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
1051,62,Uveitis-glaucoma-hyphaema syndrome,Eye and ear procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1052,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1053,1,Skin depigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
1054,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1055,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1055,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1055,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1055,4,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1056,1,Headache,Headaches NEC,Headaches,Nerv,N
1057,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1057,2,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1058,1,Lipoatrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
1058,2,Skin depigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
1059,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1060,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1060,2,Documented hypersensitivity to administered product,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1060,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1060,4,Headache,Headaches NEC,Headaches,Nerv,N
1060,5,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
1060,6,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1061,1,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
1062,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1063,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1064,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1064,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1064,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1064,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1065,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1066,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1066,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1067,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1067,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1068,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1068,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1068,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1068,4,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1068,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1069,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1070,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1070,2,Feeling jittery,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1070,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1070,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1071,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1071,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1071,3,Rotator cuff syndrome,Joint related disorders NEC,Joint disorders,Musc,N
1072,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1073,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1073,2,Skin texture abnormal,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1074,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1074,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1075,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1075,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1076,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1076,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1076,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1076,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1076,5,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1076,6,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1077,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1077,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1078,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1078,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1078,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1078,4,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1079,1,Headache,Headaches NEC,Headaches,Nerv,N
1079,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1079,3,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1080,1,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1081,1,Migraine,Migraine headaches,Headaches,Nerv,N
1082,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1082,2,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
1082,3,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1082,4,Synovial rupture,Bone and joint injuries NEC,Bone and joint injuries,Inj&P,N
1083,1,Electrocardiogram T wave amplitude decreased,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1083,2,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1084,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1084,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1084,3,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
1084,4,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1084,5,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1084,6,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1084,7,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1084,8,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1084,9,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1084,10,Inflammation,Inflammations,General system disorders NEC,Genrl,N
1084,11,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1084,12,Joint range of motion decreased,Joint related signs and symptoms,Joint disorders,Musc,N
1084,13,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1084,14,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1084,15,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1084,16,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1084,17,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1084,18,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1084,19,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1084,20,Rotator cuff syndrome,Joint related disorders NEC,Joint disorders,Musc,N
1084,21,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1085,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1085,2,Hypertrophic scar,Skin dystrophies,Cornification and dystrophic skin disorders,Skin,N
1085,3,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1085,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1086,1,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1087,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1087,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1087,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1088,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1088,2,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
1088,3,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
1088,4,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1088,5,Suspected product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1088,6,Synovial rupture,Bone and joint injuries NEC,Bone and joint injuries,Inj&P,N
1089,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1090,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1090,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1090,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
1090,4,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1090,5,Suspected product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1091,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1092,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1092,2,Trigger finger,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
1093,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1093,2,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1093,3,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
1093,4,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1093,5,Eye infection,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
1093,6,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
1093,7,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
1093,8,Headache,Headaches NEC,Headaches,Nerv,N
1093,9,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1093,10,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1093,11,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1093,12,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1093,13,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1093,14,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1093,15,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1093,16,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1094,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1094,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1095,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1096,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1096,2,Blindness unilateral,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1096,3,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1096,4,Cellulitis orbital,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1096,5,Cystoid macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
1096,6,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1096,7,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
1096,8,Headache,Headaches NEC,Headaches,Nerv,N
1096,9,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1096,10,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1096,11,Impaired quality of life,Social issues NEC,Lifestyle issues,SocCi,N
1096,12,Impaired work ability,Disability issues,Lifestyle issues,SocCi,N
1096,13,Infection susceptibility increased,Infections NEC,Infections - pathogen unspecified,Infec,N
1096,14,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
1096,15,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1096,16,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1096,17,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1096,18,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
1096,19,Psychiatric symptom,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1096,20,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1096,21,Uveitis-glaucoma-hyphaema syndrome,Eye and ear procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1097,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1098,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1098,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1098,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1098,4,Tendon rupture,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
1098,5,Tendonitis,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
1099,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1100,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1100,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1100,3,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1100,4,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1100,5,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1100,6,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1100,7,Headache,Headaches NEC,Headaches,Nerv,N
1100,8,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1100,9,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1100,10,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1100,11,Pulse abnormal,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1100,12,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1101,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1101,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1102,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1102,2,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
1102,3,Femur fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1103,1,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1104,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1104,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1104,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1105,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1106,1,Administration site joint infection,Bone and joint infections,Infections - pathogen unspecified,Infec,N
1107,1,Finger deformity,Extremity deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
1107,2,Foreign body reaction,Inflammations,General system disorders NEC,Genrl,N
1107,3,Injection site calcification,Injection site reactions,Administration site reactions,Genrl,N
1108,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1109,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1109,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1109,3,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1109,4,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
1109,5,Nasal dryness,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1109,6,Nasal obstruction,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1110,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1111,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1111,2,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1111,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1111,4,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1111,5,Irregular sleep wake rhythm disorder,Disturbances in sleep phase rhythm,Sleep disturbances (incl subtypes),Nerv,N
1111,6,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1111,7,Postmenopausal haemorrhage,Menopausal effects on the genitourinary tract,Menopause related conditions,Repro,N
1112,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1112,2,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
1112,3,Femur fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1113,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1114,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1115,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1115,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1115,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1116,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1116,2,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1116,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1117,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1117,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1117,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1118,1,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1118,2,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
1119,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1120,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1121,1,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
1122,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1122,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1122,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1123,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1123,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1123,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1123,4,Sleep terror,Parasomnias,Sleep disorders and disturbances,Psych,N
1124,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1125,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1125,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1126,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1126,2,Headache,Headaches NEC,Headaches,Nerv,N
1127,1,Uterine haemorrhage,Uterine disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
1128,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1128,2,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1128,3,Drug clearance decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1128,4,Hypovolaemia,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1128,5,Urine output decreased,Urinary tract function analyses NEC,Renal and urinary tract investigations and urinalyses,Inv,N
1129,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1129,2,Cystoid macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
1129,3,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1129,4,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1129,5,Macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
1129,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1130,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1130,2,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1130,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1130,4,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1130,5,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1130,6,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1130,7,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1130,8,Headache,Headaches NEC,Headaches,Nerv,N
1130,9,Heart rate irregular,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1130,10,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1130,11,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1130,12,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1130,13,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
1130,14,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1130,15,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1130,16,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1130,17,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1131,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1131,2,Eczema herpeticum,Herpes viral infections,Viral infectious disorders,Infec,N
1131,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1131,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1131,5,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1131,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1131,7,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1131,8,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1131,9,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1131,10,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1131,11,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1132,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1132,2,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
1133,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1134,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1135,1,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
1135,2,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
1136,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1136,2,Mouth haemorrhage,Oral soft tissue haemorrhages,Oral soft tissue conditions,Gastr,N
1136,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1136,4,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
1137,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1138,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1139,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1139,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1139,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1140,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1141,1,Injection site alopecia,Injection site reactions,Administration site reactions,Genrl,N
1141,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1142,1,Injection site alopecia,Injection site reactions,Administration site reactions,Genrl,N
1142,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1143,1,Injection site alopecia,Injection site reactions,Administration site reactions,Genrl,N
1143,2,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
1143,3,Injection site discolouration,Injection site reactions,Administration site reactions,Genrl,N
1143,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1144,1,Drug effective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1144,2,Injection site alopecia,Injection site reactions,Administration site reactions,Genrl,N
1144,3,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
1144,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1145,1,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1146,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1146,2,Injection site joint erythema,Injection site reactions,Administration site reactions,Genrl,N
1146,3,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1147,1,Greater trochanteric pain syndrome,Joint related disorders NEC,Joint disorders,Musc,N
1148,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1149,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1149,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1149,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1150,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1150,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1151,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1151,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1151,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1151,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1151,5,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1152,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1153,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1154,1,Postmenopausal haemorrhage,Menopausal effects on the genitourinary tract,Menopause related conditions,Repro,N
1155,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1156,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1156,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1156,3,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1156,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1156,5,Postmenopausal haemorrhage,Menopausal effects on the genitourinary tract,Menopause related conditions,Repro,N
1156,6,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1157,1,Headache,Headaches NEC,Headaches,Nerv,N
1157,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
1157,3,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1158,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1159,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
1160,1,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
1161,1,Tongue discolouration,Tongue signs and symptoms,Tongue conditions,Gastr,N
1162,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1162,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1162,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1162,4,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1162,5,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1162,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1162,7,Headache,Headaches NEC,Headaches,Nerv,N
1162,8,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1162,9,Menstrual disorder,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
1162,10,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
1162,11,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1162,12,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1163,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1164,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1165,1,Injection site haematoma,Injection site reactions,Administration site reactions,Genrl,N
1166,1,Lipoatrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
1166,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1166,3,Scar,Skin injuries NEC,Injuries NEC,Inj&P,N
1167,1,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
1167,2,Hypopyon,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
1167,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1168,1,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
1168,2,Hypopyon,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
1168,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1169,1,Affect lability,Affect alterations NEC,Mood disorders and disturbances NEC,Psych,N
1170,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1170,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1170,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1170,4,Inflammation,Inflammations,General system disorders NEC,Genrl,N
1170,5,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1171,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
1171,2,Hypopyon,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
1171,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1172,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1172,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1172,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1172,4,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1172,5,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1173,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1173,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
1174,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1174,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1174,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1174,4,Migraine,Migraine headaches,Headaches,Nerv,N
1174,5,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1175,1,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
1176,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1176,2,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1177,1,Blepharospasm,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
1178,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1178,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1178,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1178,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1178,5,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1178,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1178,7,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1178,8,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1178,9,Therapy cessation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1179,1,Headache,Headaches NEC,Headaches,Nerv,N
1179,2,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
1179,3,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
1180,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1181,1,Atrophy,Trophic disorders,Tissue disorders NEC,Genrl,N
1182,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1183,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1183,2,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
1183,3,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1184,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1185,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1186,1,Capillary nail refill test,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1187,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1187,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1187,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1187,4,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
1188,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1189,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1190,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1190,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1191,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1192,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1193,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1194,1,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
1194,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1195,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1195,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1195,3,Topical steroid withdrawal reaction,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1196,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1197,1,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
1198,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1198,2,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1198,3,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1198,4,Headache,Headaches NEC,Headaches,Nerv,N
1198,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1198,6,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1198,7,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1199,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1200,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1201,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1202,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1202,2,Feeling of body temperature change,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1203,1,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
1204,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1205,1,Intra-ocular injection complication,Eye and ear procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1205,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1206,1,Injection site deformation,Injection site reactions,Administration site reactions,Genrl,N
1207,1,Injection site indentation,Injection site reactions,Administration site reactions,Genrl,N
1207,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1208,1,Polymenorrhoea,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
1209,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1210,1,Nerve injury,Nerve injuries NEC,Injuries NEC,Inj&P,N
1211,1,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
1212,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1212,2,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1212,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1213,1,Postmenopausal haemorrhage,Menopausal effects on the genitourinary tract,Menopause related conditions,Repro,N
1214,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1215,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1215,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1215,3,Headache,Headaches NEC,Headaches,Nerv,N
1216,1,Menstrual disorder,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
1217,1,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1218,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1218,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1218,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1218,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1218,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1219,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1219,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1219,3,Lymph node pain,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1219,4,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1219,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1220,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1220,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1220,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1220,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1221,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1221,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1221,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1221,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1222,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1223,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1224,1,Tongue disorder,Tongue disorders,Tongue conditions,Gastr,N
1225,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1226,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1226,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1226,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1226,4,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1226,5,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1226,6,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1226,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1226,8,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1226,9,Skin tightness,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1226,10,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1227,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1227,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1227,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1227,4,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1227,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1227,6,Skin tightness,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1227,7,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1228,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1228,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1228,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1229,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1229,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1229,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1229,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1230,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1231,1,Anisocoria,Pupil disorders,Ocular neuromuscular disorders,Eye,N
1231,2,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
1231,3,Eyelid ptosis,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
1231,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1231,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1232,1,Adverse reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1233,1,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
1234,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
1235,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1236,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1237,1,Lipoatrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
1237,2,Skin depigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
1238,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1238,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1239,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1240,1,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1241,1,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1242,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1243,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1244,1,Atrophy,Trophic disorders,Tissue disorders NEC,Genrl,N
1244,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1244,3,Skin depigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
1245,1,Atrophy,Trophic disorders,Tissue disorders NEC,Genrl,N
1245,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1245,3,Skin depigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
1246,1,Perioral dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1247,1,Headache,Headaches NEC,Headaches,Nerv,N
1248,1,Headache,Headaches NEC,Headaches,Nerv,N
1248,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1248,3,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1249,1,Headache,Headaches NEC,Headaches,Nerv,N
1249,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1249,3,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1250,1,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
1250,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1251,1,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
1251,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1252,1,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1253,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1253,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1254,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1255,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1255,2,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1255,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1255,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1255,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1255,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1256,1,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
1256,2,Skin hyperpigmentation,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
1257,1,Lipoatrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
1258,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1258,2,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
1258,3,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
1258,4,Skin depigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
1259,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1260,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
1260,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1261,1,Body temperature,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1261,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1261,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1261,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1262,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1263,1,Postmenopausal haemorrhage,Menopausal effects on the genitourinary tract,Menopause related conditions,Repro,N
1264,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1264,2,Headache,Headaches NEC,Headaches,Nerv,N
1264,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1264,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1265,1,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1266,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1266,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1266,3,Headache,Headaches NEC,Headaches,Nerv,N
1267,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1267,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1267,3,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
1268,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1268,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1269,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1270,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1270,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1271,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1271,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1271,3,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1272,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1272,2,Skin hypopigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
1273,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1273,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1273,3,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1273,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1273,5,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1274,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1275,1,Lipoatrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
1275,2,Skin hyperpigmentation,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
1276,1,Skin hypopigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
1277,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1277,2,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
1278,1,Injection site discolouration,Injection site reactions,Administration site reactions,Genrl,N
1279,1,Gastrointestinal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1280,1,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
1281,1,Bone density decreased,Musculoskeletal and soft tissue imaging procedures,Musculoskeletal and soft tissue investigations (excl enzyme tests),Inv,N
1281,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1281,3,Wrist fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1282,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1282,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1282,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1282,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1282,5,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1282,6,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1283,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1283,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1283,3,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1283,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1283,5,Pseudolymphoma,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1284,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1284,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1284,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1284,4,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1284,5,Headache,Headaches NEC,Headaches,Nerv,N
1284,6,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1284,7,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1284,8,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1285,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
